{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:09:15Z","timestamp":1722470955004},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1007\/s11912-003-0013-y","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T15:02:46Z","timestamp":1180105366000},"page":"510-515","source":"Crossref","is-referenced-by-count":9,"title":["Juvenile myelomonocytic leukemia"],"prefix":"10.1007","volume":"5","author":[{"given":"Charlotte Marie","family":"Niemeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kratz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"13_CR1","first-page":"3534","volume":"89","author":"CM Niemeyer","year":"1997","unstructured":"Niemeyer CM, Aric\u00d2 M, Basso G, et al.: Chronic myelomonocytic leukemia in childhood: a report of 110 cases. Blood 1997, 89:3534\u20133543. A comprehensive description of clinical features of the largest series of patients with JMML.","journal-title":"Blood"},{"key":"13_CR2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood.V91.1.365","volume":"91","author":"D Pinkel","year":"1998","unstructured":"Pinkel D: Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 1998, 91:365\u2013367.","journal-title":"Blood"},{"key":"13_CR3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V77.5.925.925","volume":"77","author":"PD Emanuel","year":"1991","unstructured":"Emanuel PD, Bates LJ, Castleberry RP, et al.: Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991, 77:925\u2013929.","journal-title":"Blood"},{"key":"13_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.leu.2401240","volume":"13","author":"C Flotho","year":"1999","unstructured":"Flotho C, Valcamonica S, Mach-Pascual S, et al.: RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 1999, 13:32\u201337.","journal-title":"Leukemia"},{"key":"13_CR5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V92.1.267.413a31_267_272","volume":"92","author":"LE Side","year":"1998","unstructured":"Side LE, Emanuel PD, Taylor B, et al.: Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 1998, 92:267\u2013272.","journal-title":"Blood"},{"key":"13_CR6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJM199706123362404","volume":"336","author":"L Side","year":"1997","unstructured":"Side L, Taylor B, Cayouette M, et al.: Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 1997, 336:1713\u20131720. This paper provides evidence that NF1 functions as a tumor suppressor gene in JMML and that neurofibromin is a regulator of Ras in early myelopoiesis.","journal-title":"N Engl J Med"},{"key":"13_CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng0296-144","volume":"12","author":"G Bollag","year":"1996","unstructured":"Bollag G, Clapp DW, Shih S, et al.: Loss of NF1 results in activation of the RAS signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 1996, 12:144\u2013148. This paper confirms the specific role of neurofibromin in negatively regulating GM-CSF signaling through Ras in hematopoietic cells.","journal-title":"Nat Genet"},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1097-2765(00)80415-3","volume":"5","author":"RA Birnbaum","year":"2000","unstructured":"Birnbaum RA, O\u2019Marcaigh A, Wardak Z, et al.: NF1 and GMCSF interact in myeloid leukemogenesis. Mol Cell 2000, 5:189\u2013195.","journal-title":"Mol Cell"},{"key":"13_CR9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-3476(97)70273-7","volume":"130","author":"B Bader-Meunier","year":"1997","unstructured":"Bader-Meunier B, Tchernia G, Mielot F, et al.: Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 1997, 130:885\u2013889.","journal-title":"J Pediatr"},{"key":"13_CR10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","volume":"34","author":"M Tartaglia","year":"2003","unstructured":"Tartaglia M, Niemeyer CM, Song X, et al.: Somatic PTPN11 mutations in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003, 34:148\u2013150.","journal-title":"Nat Genet"},{"key":"13_CR11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mpo.2950120108","volume":"12","author":"PG Steinherz","year":"1984","unstructured":"Steinherz PG, Exelby PR, Young J, et al.: Splenectomy after angiographic embolization of the splenic artery in patients with massive splenomegaly and severe thrombocytopenia in juvenile subacute myelomonocytic leukemia. Med Pediatr Oncol 1984, 12:28\u201332.","journal-title":"Med Pediatr Oncol"},{"key":"13_CR12","first-page":"1111","volume":"18","author":"P Lutz","year":"1996","unstructured":"Lutz P, Zix-Kieffer I, Souillet G, et al.: Juvenile myelomonocytic leukemia: analyses of treatment results in the EORTC Children\u2019s Leukemia Cooperative Group (CLCG). Bone Marrow Transplant 1996, 18:1111\u20131116.","journal-title":"Bone Marrow Transplant"},{"key":"13_CR13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1200\/JCO.1997.15.2.566","volume":"15","author":"F Locatelli","year":"1997","unstructured":"Locatelli F, Niemeyer C, Angelucci E, et al.: Allogenic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol 1997, 15:566\u2013573. This paper offers an analysis of many children transplanted for JMML. It is a good review and interpretation of published results with SCT in patients with JMML.","journal-title":"J Clin Oncol"},{"key":"13_CR14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1182\/blood.V49.4.559.559","volume":"49","author":"JS Lilleyman","year":"1977","unstructured":"Lilleyman JS, Harrison JF, Black JA: Treatment of juvenile chronic myeloid leukemia with sequential subcutaneous cytarabine and oral mercaptopurine. Blood 1977, 49:559\u2013562.","journal-title":"Blood"},{"key":"13_CR15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/1097-0142(1984)54:4<675::AID-CNCR2820540415>3.0.CO;2-Q","volume":"54","author":"H Castro-Malaspina","year":"1984","unstructured":"Castro-Malaspina H, Schaison G, Passe S, et al.: Subacute and chronic myelomonocytic leukemia in children (juvenile CML): Clinical and hematologic observations and identification of prognostic factors. Cancer 1984, 54:675\u2013686.","journal-title":"Cancer"},{"key":"13_CR16","first-page":"730","volume":"1","author":"J Laver","year":"1987","unstructured":"Laver J, Kushner BH, Steinherz PG: Juvenile chronic myeloid leukemia: therapeutic insights. Leukemia 1987, 1:730\u2013733.","journal-title":"Leukemia"},{"key":"13_CR17","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.1987.5.12.1960","volume":"5","author":"HS Chan","year":"1987","unstructured":"Chan HS, Estrov Z, Weitzman SS, et al.: The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia. J Clin Oncol 1987, 5:1960\u20131967.","journal-title":"J Clin Oncol"},{"key":"13_CR18","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/(SICI)1096-911X(199812)31:6<516::AID-MPO9>3.0.CO;2-Q","volume":"31","author":"CD DeHeredia","year":"1998","unstructured":"DeHeredia CD, Ortega JJ, Coll MT, et al.: Results of intensive chemotherapy in children with juvenile chronic myelomonocytic leukemia: a pilot study. Med Pediatr Oncol 1998, 31:516\u2013520.","journal-title":"Med Pediatr Oncol"},{"key":"13_CR19","first-page":"434","volume":"20","author":"WG Woods","year":"2002","unstructured":"Woods WG, Barnard DR, Alonzo TA, et al.: Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children\u2019s Cancer Group. J Clin Oncol 2002, 20:434\u2013440.","journal-title":"J Clin Oncol"},{"key":"13_CR20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mpo.2950180411","volume":"18","author":"RS Festa","year":"1990","unstructured":"Festa RS, Shende A, Lanzkowsky P: Juvenile chronic myelocytic leukemia: experience with intensive combination chemotherapy. Med Pediatr Oncol 1990, 18:311\u2013316.","journal-title":"Med Pediatr Oncol"},{"key":"13_CR21","first-page":"1269","volume":"10","author":"H Hasle","year":"1996","unstructured":"Hasle H, Kerndrup G, Yssing M, et al.: Intensive chemotherapy in childhood myelodysplastic syndrome. a comparison with results in acute myeloid leukemia. Leukemia 1996, 10:1269\u20131273.","journal-title":"Leukemia"},{"key":"13_CR22","first-page":"363","volume":"70","author":"J Mirro","year":"1986","unstructured":"Mirro J, Dow LW, Kalwinsky DK, et al.: Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia. Cancer Treat Rep 1986, 70:363\u2013367.","journal-title":"Cancer Treat Rep"},{"key":"13_CR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mpo.2950210115","volume":"21","author":"A Hazani","year":"1993","unstructured":"Hazani A, Barak Y, Berant M, et al.: Congenital juvenile chronic myelogenous leukemia: therapeutical trial with interferon alpha-2. Med Pediatr Oncol 1993, 21:73\u201376.","journal-title":"Med Pediatr Oncol"},{"key":"13_CR24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/mpo.2950220513","volume":"22","author":"M Suttorp","year":"1994","unstructured":"Suttorp M, Rister M, Schmitz N: Interferon-alpha-2 (IFN) plus hydroxyurea for treatment of juvenile chronic myelogenous leukemia. Med Pediatr Oncol 1994, 22:358\u2013359.","journal-title":"Med Pediatr Oncol"},{"key":"13_CR25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00444141","volume":"148","author":"M Aric\u00d2","year":"1989","unstructured":"Aric\u00d2 M, Nespoli L, Caselli D, et al.: Juvenile chronic myeloid leukaemia and alpha-interferon. Eur J Pediatr 1989, 148:379\u2013380.","journal-title":"Eur J Pediatr"},{"key":"13_CR26","first-page":"950a","volume":"11","author":"D Maybee","year":"1992","unstructured":"Maybee D, Dubowy R, Krischer J, et al.: Unusual toxicity of high-dose alpha interferon (aIFN) in the treatment of juvenile chronic myelogenous leukemia (JCML) [abstract]. Proc ASCO 1992, 11:950a.","journal-title":"Proc ASCO"},{"key":"13_CR27","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJM199412223312503","volume":"331","author":"RP Castleberry","year":"1994","unstructured":"Castleberry RP, Emanuel PD, Zuckerman KS, et al.: A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. N Engl J Med 1994, 331:1680\u20131684.","journal-title":"N Engl J Med"},{"key":"13_CR28","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199506013322216","volume":"332","author":"CH Pui","year":"1995","unstructured":"Pui CH, Arico M: Isotretinoin for juvenile chronic myelogenous leukemia. N Engl J Med 1995, 332:1520\u20131521.","journal-title":"N Engl J Med"},{"key":"13_CR29","doi-asserted-by":"crossref","first-page":"346a","DOI":"10.1182\/blood.V90.1.346","volume":"90","author":"RP Castleberry","year":"1997","unstructured":"Castleberry RP, Chang M, Maybee D, et al.: A phase II study of 13-cis retinoic acid in juvenile myelomonoctic leukemia [abstract]. Blood 1997, 90:346a.","journal-title":"Blood"},{"key":"13_CR30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.bmt.1702522","volume":"26","author":"S Matthes-Martin","year":"2000","unstructured":"Matthes-Martin S, Mann G, Peters C, et al.: Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature. Bone Marrow Transplant 2000, 26:377\u2013382. A good review and interpretation of published results of SCT in patients with JMML.","journal-title":"Bone Marrow Transplant"},{"key":"13_CR31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.leu.2402407","volume":"16","author":"A Manabe","year":"2002","unstructured":"Manabe A, Okamura J, Yumura-Yagi K, et al.: Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group. Leukemia 2002, 16:645\u2013649.","journal-title":"Leukemia"},{"key":"13_CR32","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1182\/blood.V71.4.1144.bloodjournal7141144","volume":"71","author":"JE Sanders","year":"1988","unstructured":"Sanders JE, Buckner CD, Thomas ED, et al.: Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood 1988, 71:1144\u20131146.","journal-title":"Blood"},{"key":"13_CR33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.0007-1048.2001.03333.x","volume":"116","author":"FO Smith","year":"2002","unstructured":"Smith FO, King R, Nelson G, et al.: Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemia. Br J Haematol 2002, 116:716\u2013724. This paper describes the result of unrelated donor transplants in a register population.","journal-title":"Br J Haematol"},{"key":"13_CR34","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2002-07-2011","volume":"101","author":"A Worth","year":"2003","unstructured":"Worth A, Rao K, Webb D, et al.: Successful treatment of juvenile myelomonocytic leukemia relapsing post stem cell transplant using donor lymphocyte infusion. Blood 2003, 101:1713\u20131714.","journal-title":"Blood"},{"key":"13_CR35","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1182\/blood.V90.12.4910","volume":"90","author":"PO Iversen","year":"1997","unstructured":"Iversen PO, Turczynowicz S, Lewis J, et al.: A second generation GM-CSF analogue that prevents dissemination and induces remission of human juvenile myelomonocytic leukemia in engrafted immunodeficient mice. Blood 1997, 90:4910\u20134917.","journal-title":"Blood"},{"key":"13_CR36","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.V99.7.2615","volume":"99","author":"F Bernard","year":"2002","unstructured":"Bernard F, Thomas C, Emile JF, et al.: Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia. Blood 2002, 99:2615\u20132616.","journal-title":"Blood"},{"key":"13_CR37","first-page":"4279","volume":"92","author":"AE Frankel","year":"1998","unstructured":"Frankel AE, Lilly M, Kreitman R, et al.: Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia. Blood 1998, 92:4279\u20134286.","journal-title":"Blood"},{"key":"13_CR38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood.V95.2.639","volume":"95","author":"PD Emanuel","year":"2000","unstructured":"Emanuel PD, Snyder RC, Wiley T, et al.: Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors. Blood 2000, 95:639\u2013645. An excellent summary of the pathophysiology of JMML.","journal-title":"Blood"},{"key":"13_CR39","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1182\/blood.V94.7.2469.419a01_2469_2476","volume":"94","author":"N Mahgoub","year":"1999","unstructured":"Mahgoub N, Taylor BR, Gratiot M, et al.: In vitro and in vivo effects of a farnesyltransferase inhibitor on NF1-deficient hematopoietic cells. Blood 1999, 94:2469\u20132476.","journal-title":"Blood"},{"key":"13_CR40","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1182\/blood.V99.11.4147","volume":"99","author":"PO Iversen","year":"2002","unstructured":"Iversen PO, Emanuel PD, Sioud M: Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth. Blood 2002, 99:4147\u20134153.","journal-title":"Blood"},{"key":"13_CR41","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/sj.leu.2402376","volume":"16","author":"PO Iversen","year":"2002","unstructured":"Iversen PO, Sorensen DR, Benestad HB: Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias. Leukemia 2002, 16:376\u2013381.","journal-title":"Leukemia"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-003-0013-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-003-0013-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-003-0013-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:18:31Z","timestamp":1587554311000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-003-0013-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1007\/s11912-003-0013-y","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}